---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-335951"
form_type: "8-K"
ticker: null
cik: "0001651311"
company_name: "Merus N.V."
filed_at: "2025-12-30T23:59:59+00:00"
generated_at: "2026-05-16T11:59:40.702759+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Merus acquired by Genmab for $97/share; 97.39% tendered; shares delisted

## Summary
- Acquisition closed on Dec 29, 2025; 73,884,293 shares (97.39%) validly tendered and cancelled at $97/share in cash.
- Back-End Merger and Cancellation effective Dec 29, 2025; no Common Shares remain outstanding.
- Nasdaq delisting requested; trading halted before open Dec 30, 2025; Form 15 to follow.
- Directors Maxine Gowen and Anand Mehra resigned effective upon Back-End Merger.
- Dutch dividend withholding tax of $10.67 per share deducted and remitted to Dutch tax authority.

## SEC filing metadata
- accession: 0001193125-25-335951
- form_type: 8-K
- cik: 0001651311
- company_name: Merus N.V.
- filed_at: 2025-12-30T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 2.01, 3.01, 3.03, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651311/000119312525335951/0001193125-25-335951-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651311/000119312525335951/d80117d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-335951
- JSON: https://secwatch.observer/filing/0001193125-25-335951.json
- Plain text: https://secwatch.observer/filing/0001193125-25-335951.txt

## Source-grounded claims
- claim_id: 93a1ca4746333163b561fb248acef2b8509f7344
  claim: Merus N.V. underwent a change of control involving Genmab A/S for $97.00 per Common Share in cash (closed 2025-12-29).
  evidence_excerpt: of Parent (“Purchaser”), to purchase all of the issued and outstanding common shares, nominal value €0.09 per share, of the Company (the “Common Shares”), in exchange for $97.00 per Common Share in cash (the “Offer Consideration”), without interest and subject to any applicable tax withholding, upon the terms and subject to the conditions set forth in the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651311/000119312525335951/0001193125-25-335951-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.